Cellares
South San Francisco, US · 5 known investors
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.
Founders & leadership
FG
Fabian GerlinghausCo-Founder and Chief Executive Officer
OK
Omar KurdiCo-Founder and President
Investors · 5
In the news
- Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investmentnatlawreview.com · 2026
- Cellares extends funding for cell therapy manufacturing - Drug Discovery World (DDW)ddw-online.com · 2026
- Cellares Raises $327M in Series D Fundingfinsmes.com · 2026
- Exclusive: Cellares raises $257M to fund global expansion as it eyes 2027 IPOendpoints.news · 2026
- Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation - Cellarescellares.com · 2026
- Cell therapy manufacturing tech startup Cellares raises $82 million | Reutersreuters.com · 2021